Douglas Pharmaceuticals, New Zealand’s largest pharmaceutical manufacturer, is staying family owned despite a number of purchase offers.
The company has been approached several times over the years about selling up and recently decided to formalise the process through an Information Memorandum (IM) to prospective purchasers via its advisors Deutsche Bank.
But after receiving the offers, Douglas Pharmaceuticals founder and managing director, Sir Graeme Douglas considers the best way forward for the company is to retain its private ownership.
The company will bolster its export activities through the addition of experienced and qualified executives with emphasis on emerging markets in Asia and Latin America.
Idealog has been covering the most interesting people, businesses and issues from the fields of innovation, design, technology and urban development for over 12 years. And we're asking for your support so we can keep telling those stories, inspire more entrepreneurs to start their own businesses and keep pushing New Zealand forward. Give over $5 a month and you will not only be supporting New Zealand innovation, but you’ll also receive a print subscription, an Idealog t-shirt and a copy of the new book by David Downs and Dr. Michelle Dickinson, No. 8 Recharged (while stocks last).